TP53 and myelodysplastic syndrome: In recent years, the biological and clinical implications of TP53 allelic state which predicted risk of death and leukemic transformation independently of the Revised International Prognostic Scoring System (IPSS-R) have been investigated in MDS and is associated with complex karyotype, few co-occurring mutations, high-risk presentation and poor outcomes (37).